The briefing
HeartBeam closed an underwritten public offering of 12.5 million common shares for gross proceeds of $10 million. The company says funds will support commercialization of its cardiac technology.
Original headline
Ainewsbreaks Heartbeam Inc. (NASDAQ: BEAT) Closes $10 Million Public Offering To Advance Cardiac Technology Commercialization